Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02666105 | Exemestane in Post-Menopausal Women With NSCLC | ||
| NCT00869323 | Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders | ||
| NCT00290654 | Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ | ||
| NCT00167167 | Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia | ||
| NCT04466098 | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) | ||
| NCT00963872 | Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer | ||
| NCT03981705 | Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer | ||
| NCT00625729 | Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia | ||
| NCT00356941 | Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC | ||
| NCT01705288 | Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT00290628 | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer | ||
| NCT02765997 | StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies | ||
| NCT01666080 | Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) | ||
| NCT03297463 | Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma | ||
| NCT00638547 | Intrathecal Enzyme Replacement for Hurler Syndrome | ||
| NCT03365661 | QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML | ||
| NCT00258427 | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia | ||
| NCT00392782 | Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease | ||
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | ||
| NCT00668564 | Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism | ||
| NCT00602693 | T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | ||
| NCT01885897 | IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT | ||
| NCT01370213 | NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases | ||
| NCT01312818 | Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) | ||
| NCT01106950 | Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) | ||
| NCT00623077 | MT2004-30: Tomotherapy for Solid Tumors | ||
| NCT04225572 | Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) | ||
| NCT05708924 | MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT02989844 | Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT | ||
| NCT00176904 | Stem Cell Transplant for Inborn Errors of Metabolism | ||
| NCT03417154 | Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS | ||
| NCT02141451 | ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL | ||
| NCT00276159 | Study of Immune Response Modifier in the Treatment of Hematologic Malignancies | ||
| NCT00003926 | Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | ||
| NCT00871689 | Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML | ||
| NCT00357565 | Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia | ||
| NCT04714372 | FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia | ||
| NCT06295757 | Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures | ||
| NCT05322408 | HCW9218 in Select Advanced Solid Tumors | ||
| NCT02227797 | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | ||
| NCT07070726 | UNTOLD Ovarian Cancer Unmet Needs Survey | ||
| NCT01850888 | MIBG for Refractory Neuroblastoma and Pheochromocytoma | ||
| NCT05643014 | Observational Study of Exposure to Environmental Toxicants Among Firefighters | ||
| NCT01962636 | Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases | ||
| NCT03294304 | BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy | ||
| NCT04090606 | Tobacco Constituents and Biomarkers | ||
| NCT00618540 | Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis | ||
| NCT05634512 | Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH. | ||
| NCT00176865 | Stem Cell Transplant for Immunologic or Histiocytic Disorders |
